Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Gilead Sciences
(NQ:
GILD
)
150.03
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Mar 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
150.03
Bid (Size)
148.50 (100)
Ask (Size)
150.03 (100)
Prev. Close
150.03
Today's Range
150.03 - 150.03
52wk Range
93.37 - 157.29
Shares Outstanding
1,253,809,440
Dividend Yield
2.11%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Compugen (CGEN) Q4 2025 Earnings Call Transcript
↗
March 02, 2026
Compugen (CGEN) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Gilead Foundation Awards $12 Million to Empower Community Health Workers and Expand HIV Prevention Initiatives Across 14 States and the District of Columbia
March 02, 2026
From
Gilead Sciences, Inc.
Via
Business Wire
Performance
YTD
+23.4%
+23.4%
1 Month
+5.0%
+5.0%
3 Month
+20.6%
+20.6%
6 Month
+33.1%
+33.1%
1 Year
+29.3%
+29.3%
More News
Read More
Arcellx President Sells $10 Million Worth of Shares After Acquisition Announcement
↗
March 02, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Arcellx President Sells $10M Worth of Shares After Acquisition Announcement
↗
March 02, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
P/E Ratio Insights for Gilead Sciences
↗
February 27, 2026
Via
Benzinga
What's going on in today's session: S&P500 movers
↗
February 27, 2026
Via
Chartmill
Uncover the latest developments among S&P500 stocks in today's session.
↗
February 27, 2026
Via
Chartmill
Gilead Sciences Stock: Is GILD Outperforming the Healthcare Sector?
February 27, 2026
Via
Barchart.com
Topics
ETFs
Kymera (KYMR) Q4 2025 Earnings Call Transcript
↗
February 26, 2026
Via
The Motley Fool
Topics
Earnings
Merck's Two-Drug HIV Regimen Challenges Industry Standards Following Positive Phase 3 Results
February 26, 2026
Via
MarketMinute
Topics
Intellectual Property
Arcus (RCUS) Q4 2025 Earnings Call Transcript
↗
February 25, 2026
Via
The Motley Fool
Topics
Earnings
Gilead’s Twice-Yearly HIV Breakthrough: A Paradigm Shift in Global Prevention and Market Dominance
February 25, 2026
Via
MarketMinute
Topics
Intellectual Property
Eli Lilly Bolsters Genetic Medicine Portfolio with $2.4 Billion Acquisition of Orna Therapeutics
February 25, 2026
Via
MarketMinute
Topics
Intellectual Property
Gilead’s Single-Tablet Regimen of Bictegravir and Lenacapavir Maintained Virological Suppression in People With HIV Who Switched Antiretroviral Therapy
February 25, 2026
From
Gilead Sciences, Inc.
Via
Business Wire
Gilead Snaps Up Arcellx For $115 Per Share — A $7.8 Billion Bet On Cancer Therapy
↗
February 25, 2026
Via
Benzinga
Is Amgen Stock Outperforming the Dow?
February 25, 2026
Via
Barchart.com
Topics
Stocks
2 Nasdaq 100 Stocks Worth Your Attention and 1 We Question
February 24, 2026
Via
StockStory
Gilead Sciences to Present at Upcoming Investor Conferences
February 23, 2026
From
Gilead Sciences, Inc.
Via
Business Wire
Gilead Bets Big On Anito-Cel With $7.8 Billion Arcellx Deal
↗
February 23, 2026
Via
Investor's Business Daily
Gilead Buys Arcellx To Fast-Track Next-Gen Myeloma Drug
↗
February 23, 2026
Via
Benzinga
Why Did ACLX Stock Surge 80% In Pre-Market Today?
↗
February 23, 2026
Via
Stocktwits
Gilead Sciences to Acquire Arcellx to Maximize Long-term Potential of Anito-cel
February 23, 2026
From
Arcellx, Inc.
Via
Business Wire
Nurix Stock Is Down 6% This Past Year, but One Biotech Fund Still Boosted Its Bet By $63 Million
↗
February 22, 2026
Via
The Motley Fool
Where Gilead Sciences Stands With Analysts
↗
February 20, 2026
Via
Benzinga
Peering Into Gilead Sciences Inc's Recent Short Interest
↗
February 19, 2026
Via
Benzinga
Frequently Asked Questions
Is Gilead Sciences publicly traded?
Yes, Gilead Sciences is publicly traded.
What exchange does Gilead Sciences trade on?
Gilead Sciences trades on the Nasdaq Stock Market
What is the ticker symbol for Gilead Sciences?
The ticker symbol for Gilead Sciences is GILD on the Nasdaq Stock Market
What is the current price of Gilead Sciences?
The current price of Gilead Sciences is 150.03
When was Gilead Sciences last traded?
The last trade of Gilead Sciences was at 03/02/26 04:00 PM ET
What is the market capitalization of Gilead Sciences?
The market capitalization of Gilead Sciences is 188.11B
How many shares of Gilead Sciences are outstanding?
Gilead Sciences has 188B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.